Biophytis (EPA:ALBPS)

BRIEF

published on 10/30/2026 at 23:05, 2 days 5 hours ago

Biophytis Reports Positive Half-Year 2026 Financial Results and Strategic Advances

Financial Results Strategic Partnerships Biophytis Clinical Programs 2026 Progress
REGULATED PRESS RELEASE

published on 10/30/2026 at 23:00, 2 days 5 hours ago

BIOPHYTIS REPORTS FIRST- HALF 2026 RESULTS AND PROVIDES AN UPDATE ON ITS STRATEGY
BRIEF

published on 10/22/2026 at 17:35, 10 days 10 hours ago

Biophytis Invites Shareholders to Upcoming General Meeting Amid Strategic Developments

Biophytis General Meeting Shareholder Resolutions BIO101 Obesity And Sarcopenia
REGULATED PRESS RELEASE

published on 10/22/2026 at 17:30, 10 days 10 hours ago

Chairman's Letter - General Meeting Invitation
Biophytis invites shareholders to General Meeting to discuss milestones in BIO101 development for obesity and sarcopenia, introducing resolutions for strategic development and financing

Biophytis General Meeting Sarcopenia BIO101 Obesity
BRIEF

published on 09/11/2026 at 07:05, 1 month 20 days ago

Biophytis Completes €5.3 Million Capital Increase to Fund Obesity Trial

Biophytis Capital Increase Clinical Study BIO101 Obesity Trial
REGULATED PRESS RELEASE

published on 09/11/2026 at 07:00, 1 month 20 days ago

BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Biophytis completes €5.3 million capital increase to fund Phase 2 trial in obesity, balancing US and European investors. Proceeds target fat loss and muscle preservation with BIO101

Biophytis Capital Increase Phase 2 Trial BIO101 Obesity
BRIEF

published on 08/31/2026 at 07:05, 2 months 1 day ago

Biophytis Strengthens Financial Position with Cash Runway into 2027

Biophytis Debt Reduction Financial Restructuring Clinical Studies Share Warrants
REGULATED PRESS RELEASE

published on 08/31/2026 at 07:00, 2 months 1 day ago

Biophytis strengthens its financial position and extends its cash runway into Q1 2027
Biophytis strengthens financial position, extends cash runway to Q1 2027. Cash inflows of €3.7M, debt reduction of over 30%. Phase 2 study in obesity in Q1 2027

Biophytis Financial Position Debt Reduction Obesity Study Cash Runway
PRESS RELEASE

published on 08/31/2026 at 06:59, 2 months 1 day ago

Biophytis strengthens its financial position and extends its cash runway into Q1 2027
Biophytis strengthens financial position and extends cash runway to Q1 2027 through new resources and debt reduction, starting Phase 2 obesity study in Q1 2027

Biophytis Financial Position Debt Reduction Phase 2 Study Cash Runway
BRIEF

published on 08/10/2026 at 07:05, 2 months 22 days ago

Biophytis Secures Approval for OBA Clinical Trial in Brazil

Biophytis Obesity Treatment BIO101 GLP-1 Therapies OBA Clinical Trial

Published on 10/30/2026 at 23:35, 2 days 4 hours ago

Prospect Ridge Announces Closing of Critical Metals Flow-through Unit Private Placement
Published on 10/30/2026 at 23:30, 2 days 4 hours ago

Revolve Enters into Definitive Agreement to Acquire Three Project, 6 MW Battery Storage Portfolio in Ontario
Published on 10/30/2026 at 20:47, 2 days 7 hours ago

CoTec Holdings Corp. Comments on Share Trading
Published on 10/30/2026 at 19:00, 2 days 9 hours ago

Electric Royalties Ltd. Announces Application for Warrant Extension
Published on 10/30/2026 at 15:30, 2 days 12 hours ago

Bluejay Diagnostics Announces 1-for-4 Reverse Stock Split

View all ACCESSWIRE

Published on 11/01/2026 at 10:35, 17 hours 39 minutes ago

Shenzhen Unveils APEC China 2026 Host-City Theme Song and Music Video
Published on 11/01/2026 at 05:00, 23 hours 14 minutes ago

2026 Yangtze River Culture Festival Opens in Yonglian Village, Zhangjiagang, Jiangsu
Published on 10/31/2026 at 16:35, 1 day 11 hours ago

SKYWORTH Solar Announces Global Launch of Solavita as a Smart Microgrid Brand
Published on 10/30/2026 at 22:49, 2 days 5 hours ago

EQS-Adhoc: STRATEC SELLS LOSS-MAKING BUSINESS, RECOGNIZES IMPAIRMENTS, AND AMENDS GUIDANCE
Published on 10/30/2026 at 22:30, 2 days 5 hours ago

/C O R R E C T I O N - OCI Global/

View all EQS

Published on 10/30/2026 at 23:00, 2 days 5 hours ago

BIOPHYTIS REPORTS FIRST- HALF 2026 RESULTS AND PROVIDES AN UPDATE ON ITS STRATEGY
Published on 10/30/2026 at 20:42, 2 days 7 hours ago

TINC and PMV invest in Storm Group (B)
Published on 10/30/2026 at 18:00, 2 days 10 hours ago

2026 half-year earnings & third quarter revenue
Published on 10/30/2026 at 12:00, 2 days 16 hours ago

Capital increase through exercise of subscription rights
Published on 10/30/2026 at 08:45, 2 days 19 hours ago

Share buyback

View all LES ECHOS COMFI WIRE

News